GLP-1 drugs approved by the Food and Drug Administration (FDA) include semaglutide (brand names Wegovy, Ozempic and Rybelsus), tirzepatide (brand names Zepbound and Mounjaro) and liraglutide (brand name Saxenda)
When weight is gained, the skin stretches to accommodate the bodys increased volume
What we'd expect long-term based on available data: Weight loss continues through at least 104 weeks in most patients Estimated peak loss: 3032% in patients reaching maximum dose and maintaining treatment Maintenance phase: stable weight if treatment continues without dose reduction Weight regain after stopping is near-universal with all GLP-1 medications
Fats get broken down into ketone bodies which are then used to fuel the body, in place of glucose
Sunman, H., Canpolat, U., Sahiner, L
If you eat too soon or drink too much of the water, the medicine will not be absorbed well